Nexsen Limited (ASX:NXN)

Australia flag Australia · Delayed Price · Currency is AUD
0.1850
+0.0050 (2.78%)
At close: May 12, 2026
Market Cap36.04M
Revenue (ttm)931.61K +47.4%
Net Income-8.46M
EPS-0.04
Shares Out200.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume410,975
Average Volume412,187
Open0.1850
Previous Close0.1800
Day's Range0.1750 - 0.1900
52-Week Range0.1300 - 0.3150
Betan/a
RSI46.05
Earnings DateMay 27, 2026

About Nexsen

Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a... [Read more]

Industry Commercial Physical and Biological Research
Founded 2021
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol NXN
Full Company Profile

Financial Performance

Financial Statements